Clinical Trial Update: Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept trial is evaluating fezolinetant for vasomotor symptoms in men with prostate cancer on androgen deprivation therapy; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Fezolinetant (fezolinetant)

Snippet

Sponsor: Shehzad Basaria, M.D. | Conditions: Prostate Cancer, Prostate Cancer (Adenocarcinoma) | Phase 2 | Status: RECRUITING